Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Adenocarcinoma × Genitourinary × Clear all

Phase

Status

Sponsor Class

OTHER 67 INDUSTRY 29 NIH 2 UNKNOWN 1 OTHER_GOV 1 NETWORK 1 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Head & Neck 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Prostatic Neoplasms 121 Urinary Bladder Neoplasms 44 Kidney Neoplasms 34 Carcinoma, Renal Cell 28 Wilms Tumor 23 Urethral Neoplasms 15 Testicular Neoplasms 15 Neoplasm Metastasis 13 Breast Neoplasms 12 Ovarian Neoplasms 11 Neuroblastoma 10 Sarcoma 9 Carcinoma, Non-Small-Cell Lung 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lung Neoplasms 7 Neoplasms 6 Endodermal Sinus Tumor 6 Colorectal Neoplasms 6 Colonic Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Burkitt Lymphoma 6 Testicular Germ Cell Tumor 5 Teratoma 5 Ovarian Germ Cell Cancer 5 Head and Neck Neoplasms 5 Breast Neoplasms, Male 5 Teratoma, Testicular 4 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Seminoma 4

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1 abiraterone 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06592924 2026-01-14

TRIPLE-SWITCH

Canadian Cancer Trials Group

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡